Page 3 - தூய்மையானது மாற்று தீர்வுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BIRMINGHAM, Ala. /Massachusetts Newswire – National News/ Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with The University of Alabama at Birmingham (UAB), a leading institution in transplant research, to develop a new class of transplant diagnostics aimed at the detection and identification of HLA-specific memory B cells which are poised to produce HLA-specific immunoglobulin injurious to transplanted grafts. The research is being led by Dr. Frances Lund, Charles H. McCauley Professor and Chair Department of Microbiology, Dr. John Killian, resident in the Department of Surgery, and Dr. Rico Buchli, VP of Products and Services at PTS, and focuses on using PTS’s newly created Class I and Class II biotinylated soluble HLA (sHLA) proteins to u

University of alabama at birminghamUnited statesUniversity of alabamaJohn killianFrances lundCharlesh mccauleyJohn killian jrUniversity of alabama birminghamEmergent technologies incPure proteinPure transplant solutionsDepartment of surgeryDepartment of microbiologyUniversity of oklahomaNational newsUniversity of alabama system